232 related articles for article (PubMed ID: 7870039)
1. Characterization of two affinity states of adenosine A2a receptors with a new radioligand, 2-[2-(4-amino-3-[125I]iodophenyl)ethylamino]adenosine.
Luthin DR; Olsson RA; Thompson RD; Sawmiller DR; Linden J
Mol Pharmacol; 1995 Feb; 47(2):307-13. PubMed ID: 7870039
[TBL] [Abstract][Full Text] [Related]
2. 125I-APE binding to adenosine receptors in coronary artery: photoaffinity labeling with 125I-azidoAPE.
Hussain T; Linden J; Mustafa SJ
J Pharmacol Exp Ther; 1996 Jan; 276(1):284-8. PubMed ID: 8558444
[TBL] [Abstract][Full Text] [Related]
3. Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
Nonaka H; Mori A; Ichimura M; Shindou T; Yanagawa K; Shimada J; Kase H
Mol Pharmacol; 1994 Nov; 46(5):817-22. PubMed ID: 7969067
[TBL] [Abstract][Full Text] [Related]
4. 125I-BW-A844U, an antagonist radioligand with high affinity and selectivity for adenosine A1 receptors, and 125I-azido-BW-A844U, a photoaffinity label.
Patel A; Craig RH; Daluge SM; Linden J
Mol Pharmacol; 1988 Jun; 33(6):585-91. PubMed ID: 3380075
[TBL] [Abstract][Full Text] [Related]
5. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
[TBL] [Abstract][Full Text] [Related]
6. Photoaffinity labeling with 2(-)[2-(4-azido-3(-)[125I]- iodophenyl)ethylamino]adenosine and autoradiography with 2(-)[2-(4-amino-3(-)[125I]iodophenyl)ethylamino]adenosine of A2a adenosine receptors in rat brain.
Luthin DR; Lee KS; Okonkwo D; Zhang P; Linden J
J Neurochem; 1995 Nov; 65(5):2072-9. PubMed ID: 7595492
[TBL] [Abstract][Full Text] [Related]
7. ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus.
Cunha RA; Constantino MD; Ribeiro JA
Br J Pharmacol; 1997 Dec; 122(7):1279-84. PubMed ID: 9421273
[TBL] [Abstract][Full Text] [Related]
8. Labeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261.
Dionisotti S; Ferrara S; Molta C; Zocchi C; Ongini E
J Pharmacol Exp Ther; 1996 Sep; 278(3):1209-14. PubMed ID: 8819504
[TBL] [Abstract][Full Text] [Related]
9. A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand binding.
Piersen CE; True CD; Wells JN
Mol Pharmacol; 1994 May; 45(5):861-70. PubMed ID: 8190103
[TBL] [Abstract][Full Text] [Related]
10. Kinetic and functional properties of [3H]ZM241385, a high affinity antagonist for adenosine A2A receptors.
Uustare A; Vonk A; Terasmaa A; Fuxe K; Rinken A
Life Sci; 2005 Feb; 76(13):1513-26. PubMed ID: 15680315
[TBL] [Abstract][Full Text] [Related]
11. Reconstitution of recombinant bovine A1 adenosine receptors in Sf9 cell membranes with recombinant G proteins of defined composition.
Figler RA; Graber SG; Lindorfer MA; Yasuda H; Linden J; Garrison JC
Mol Pharmacol; 1996 Dec; 50(6):1587-95. PubMed ID: 8967981
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of (-)[125I]hydroxyphenylisopropyladenosine, an adenosine R-site agonist radioligand and theoretical analysis of mixed stereoisomer radioligand binding.
Linden J
Mol Pharmacol; 1984 Nov; 26(3):414-23. PubMed ID: 6092894
[TBL] [Abstract][Full Text] [Related]
13. G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors.
Cunha RA; Constantino MD; Ribeiro JA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):295-302. PubMed ID: 10344528
[TBL] [Abstract][Full Text] [Related]
14. Characterization of adenosine A2 receptors in bovine retinal membranes.
Blazynski C; McIntosh H
Exp Eye Res; 1993 May; 56(5):585-93. PubMed ID: 8500567
[TBL] [Abstract][Full Text] [Related]
15. Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]-SCH 58261 binding.
Varani K; Gessi S; Dalpiaz A; Ongini E; Borea PA
Br J Pharmacol; 1997 Sep; 122(2):386-92. PubMed ID: 9313951
[TBL] [Abstract][Full Text] [Related]
16. A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase.
Hide I; Padgett WL; Jacobson KA; Daly JW
Mol Pharmacol; 1992 Feb; 41(2):352-9. PubMed ID: 1311411
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists.
Müller CE; Geis U; Hipp J; Schobert U; Frobenius W; Pawłowski M; Suzuki F; Sandoval-Ramírez J
J Med Chem; 1997 Dec; 40(26):4396-405. PubMed ID: 9435909
[TBL] [Abstract][Full Text] [Related]
18. 5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor.
van der Wenden EM; Carnielli M; Roelen HC; Lorenzen A; von Frijtag Drabbe Künzel JK; IJzerman AP
J Med Chem; 1998 Jan; 41(1):102-8. PubMed ID: 9438026
[TBL] [Abstract][Full Text] [Related]
19. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
Labbé-Jullié C; Botto JM; Mas MV; Chabry J; Mazella J; Vincent JP; Gully D; Maffrand JP; Kitabgi P
Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272
[TBL] [Abstract][Full Text] [Related]
20. Novel 3-aralkyl-7-(amino-substituted)-1,2,3-triazolo[4,5-d]pyrimidines with high affinity toward A1 adenosine receptors.
Betti L; Biagi G; Giannaccini G; Giorgi I; Livi O; Lucacchini A; Manera C; Scartoni V
J Med Chem; 1998 Feb; 41(5):668-73. PubMed ID: 9513594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
